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Abstract Receptor-regulated phospholipase D (PLD) is a key
signaling pathway implicated in the control of fundamental
biological processes. Here evidence is presented that in addition
to protein kinase C (PKC) and Rho GTPases, Ca2+ response
evoked by sphingosine 1-phosphate (S1P) also participates to the
enzyme regulation. Ca2+ was found critical for PKCK-mediated
PLD activation. Moreover, S1P-induced PLD activity resulted
diminished by calmodulin inhibitors such as W-7 and CGS9343B
implicating its involvement in the process. A plausible candidate
for Ca2+-dependent PLD regulation by S1P was represented by
calcineurin, in view of the observed reduction of the stimulatory
effect by cyclosporin A. In contrast, monomeric GTP-binding
protein Ral was translocated to membranes by S1P in a Ca2+-
independent manner, ruling out its possible role in agonist-
mediated regulation of PLD. 3 2002 Published by Elsevier
Science B.V. on behalf of the Federation of European Biochem-
ical Societies.
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1. Introduction
Phospholipase D (PLD), which hydrolyzes phosphatidyl-
choline (PtdCho) to phosphatidic acid and choline, represents
a key enzyme in membrane cell signaling. A plethora of extra-
cellular ligands including hormones, neurotransmitters and
cytokines are indeed able to activate the enzymatic activity
upon interaction with their receptors [1^4]. Activation of
PLD appears to be involved in the regulation of various fun-
damental biological events including cell proliferation and dif-
ferentiation, progression through cell cycle, vesicular tra⁄ck-
ing, cell secretion [1^4] and, more recently, receptor
endocytosis [5]. Studies performed over the last decade have
clari¢ed that two distinct isoforms, PLD1 and PLD2, account
for PLD activity in mammalian cells. Both proteins appear to
be complexly regulated, in many instances in an agonist- and
cell-speci¢c manner, but the molecular mechanisms involved
have not been fully elucidated.
Our previous studies have shown that both PLD1 and
PLD2 are expressed in C2C12 satellite muscle cells and that
PLD activity is signi¢cantly increased by sphingosine 1-phos-
phate (S1P) [6], a lysophospholipid known to exert pleiotropic
e¡ects in a variety of cell systems [7,8]. Activation of PLD by
the bioactive lipid was totally abrogated by pertussis toxin,
supporting the view that the process was dependent on the
binding of S1P to its speci¢c receptors [6]. As regards the
signaling pathways downstream of receptor coupling speci¢-
cally involved in PLD regulation, a major role was found for
protein kinase C (PKC). Indeed, Ca2þ-dependent PKC, exclu-
sively represented in C2C12 cells by the alpha isoform, as well
as PKCN, a member of the novel, Ca2þ-independent PKC
subfamily, were identi¢ed as major regulators of S1P-induced
PLD activity [6]. Moreover, monomeric GTP-binding proteins
belonging to the Rho family were also identi¢ed as modula-
tors of myoblast PLD activity by S1P: RhoA translocation/
activation elicited by the bioactive lipid, which resulted down-
stream of PKCK [9], was found involved in activation of PLD
speci¢cally localized in Golgi-enriched fractions [10]. Our ¢nd-
ings on PLD regulation by S1P in C2C12 myoblasts are in
keeping with other studies in which agonist-induced PLD ac-
tivity resulted to be concomitantly under the control of multi-
ple inputs such as PKC and monomeric Rho GTPase family
proteins [1^3]. However, several examples are reported in the
literature for participation of Ca2þ in the regulation of PLD
activity, although the e¡ector molecules involved have not
been fully characterized so far [11^14].
Given that in our recent work evidence was provided for a
signi¢cant e¡ect of S1P on intracellular Ca2þ levels in C2C12
myoblasts [15,16], we decided to address the question whether
the Ca2þ rise elicited by the bioactive lipid plays a role in the
mechanism by which S1P regulates PLD activity in skeletal
muscle cells. Here, we report that Ca2þ mobilization is impli-
cated in PLD regulation by S1P and that multiple Ca2þ e¡ec-
tors are potentially involved in the process.
2. Materials and methods
2.1. Materials
C2C12 cells were obtained from ATCC (Manassas, VA, USA). S1P
was purchased from Avanti Polar Lipids (Alabaster, AL, USA). BAP-
TA/acetoxymethyl ester (AM), cyclosporin A, and Go«6976 were
obtained from Calbiochem (La Jolla, CA, USA). Bradykinin (BK),
A23187, W-7, KN-62 were from Sigma-Aldrich (Milan, Italy).
CGS9343B (Zaldaride) was the generous gift of Dr. Jacob A. Zijlstra,
Novartis Consumer Health, Nyon, Switzerland. [3H]Glycerol (16.5 Ci/
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mmol) was purchased from Du Pont NEN (Boston, MA, USA). Fluo-
3/AM and Pluronic F-127 were from Molecular Probes (Eugene, OR,
USA). Mouse monoclonal antibodies against Ral were from Trans-
duction Laboratories (Lexington, KY, USA). Rabbit polyclonal anti-
PKCK antibodies and secondary antibodies (goat anti-mouse or anti-
rabbit immunoglobulin G1 conjugated to horseradish peroxidase) for
Western analysis were from Santa Cruz (Santa Cruz, CA, USA).
Enhanced chemiluminescence (ECL) reagents were obtained from
Amersham Pharmacia Biotech (Uppsala, Sweden).
2.2. Cell culture
C2C12 cells were maintained in Dulbecco’s modi¢ed Eagle’s me-
dium supplemented with 10% fetal bovine serum, 100 U/ml penicillin
and 100 Wg/ml streptomycin at 37‡C in a humidi¢ed atmosphere of
5% CO2/95% air. For the experiments cells were seeded into 35-mm or
100-mm diameter dishes and utilized when 90% con£uent. The day
before the experiment the cells were shifted to serum-free medium and
in some circumstances labeled overnight with [3H]glycerol.
2.3. Ca2+ imaging
Imaging of intracellular Ca2þ was obtained using a Bio-Rad MRC
1024ES (Bio-Rad, Hercules, CA, USA) confocal scanning head
coupled to a Nikon TE300 inverted microscope. Cells plated on a
coverslip were loaded with 10 WM Fluo-3/AM in the presence of
0.1% anhydrous dimethylsulfoxide (DMSO) and 0.01% (w/v) Pluronic
F-127 as dispersing agents for 10 min at room temperature and sub-
jected to laser scanning imaging essentially as described [15,16]. Fluo-
3-loaded cells were excited at 488 nm and emitted £uorescence was
collected by a Nikon Plan Apo 60U oil immersion objective through
a 510-nm long-wave pass-¢lter. Analysis of images was obtained using
the free software Confocal Assistant (Bio-Rad).
2.4. PLD in vivo assay
PLD activity was determined by measuring [3H]phosphatidyl-
ethanol (PtdEtOH) produced via PLD-catalyzed transphosphatid-
ylation in the presence of ethanol, as previously described [17]. Brie£y,
C2C12 cells were metabolically labeled by incubation with 5 WCi/ml
[3H]glycerol for 24 h. After washing with ice-cold phosphate-bu¡ered
saline (PBS) to remove unincorporated [3H]glycerol, labeled cells were
treated or not with the agonist in the presence of 2% ethanol. Incu-
bations were performed at 37‡C and terminated by washing the
monolayers twice with ice-cold PBS followed immediately by addition
of 1 ml of ice-cold methanol. Cells were collected by scraping; lipids
were then extracted essentially as described by Bligh and Dyer [18]
except that water was replaced with 1 M NaCl. [3H]PtdEtOH and
[3H]PtdCho were separated by thin-layer chromatography and quan-
ti¢ed as described [17]. [3H]PtdEtOH formed was reported as the
percentage of [3H]PtdCho. In all the experiments PLD assay was
performed in duplicate and the variation coe⁄cient was always below
8%.
2.5. Cell fractionation
Serum-starved C2C12 cells were treated or not with S1P for the
indicated times. The medium was removed and the cells washed twice
with ice-cold PBS, scraped in 20 mM HEPES, pH 7.4, 2 mM EGTA,
1 mM EDTA, 250 mM sucrose, 5 mM NaN3 containing protease
inhibitors (1 mM AEBSF, 0.3 WM aprotinin, 10 Wg/ml leupeptin
and 10 Wg/ml pepstatin) and homogenized in a Dounce homogenizer
(60 strokes). Lysates were centrifuged for 7 min at 750Ug to separate
nuclei. To prepare cytosolic and total particulate fractions, the super-
natant was centrifuged at 200 000Ug for 1 h. Protein content was
quanti¢ed according to the Coomassie blue procedure using a com-
mercially available kit (Bio-Rad).
2.6. Immunodetection
Proteins (15^25 Wg) from cellular fractions of control or stimulated
myoblasts were separated by SDS^PAGE. Proteins were electrotrans-
ferred to nitrocellulose membranes, which were incubated overnight in
Tris-bu¡ered saline containing 0.1% Tween-20 (TTBS) and 1% bovine
serum albumin. Membranes were subsequently incubated for 1 h with
antibodies against Ral or PKCK. Hybridization with primary anti-
bodies was followed by washing with TTBS and incubation with per-
oxidase-conjugated goat anti-mouse or anti-rabbit IgG1. Proteins
were detected by ECL. Quantitative analysis of the bands was per-
formed using Imaging and Analysis Software by Bio-Rad.
3. Results
To examine the sensitivity to Ca2þ of myoblast PLD, the
enzymatic activity was initially assayed in C2C12 cells incu-
bated for 10 min in the presence of the Ca2þ ionophore
A23187. As shown in Fig. 1, the addition of 3 WM A23187
provoked a signi¢cant increase of PLD activity, indicating
that Ca2þ can regulate PLD in skeletal muscle cells. Results
presented in the same ¢gure illustrate that the positive e¡ect
exerted by Ca2þ on PLD activity was reduced in cells treated
with the conventional PKC inhibitor Go«6976 (1 WM), suggest-
ing that PKCK, the sole Ca2þ-dependent isoform expressed in
these cells [6], could represent a downstream e¡ector of Ca2þ
in the signaling to PLD. It was then evaluated whether intra-
cellular Ca2þ increase participates in the agonist-mediated reg-
ulation of PLD in C2C12 cells. To this end PLD activity was
measured in myoblasts loaded for 1 h with 15 WM BAPTA/
AM, intracellular chelator of Ca2þ. In this experimental con-
dition agonist-induced rise of cytosolic Ca2þ was fully pre-
vented, as proved by the monitoring with a confocal laser
scanning £uorescent microscope of Ca2þ signals evoked by
1 WM S1P in Fluo-3-loaded myoblasts (Fig. 2A). Remarkably,
the presence of BAPTA reduced signi¢cantly the activation of
PLD by 1 WM S1P and 1 WM BK, indicating that intracellular
Ca2þ plays also a critical role in the regulation of agonist-
induced PLD activity (Fig. 2B). The possible mechanisms by
which intracellular Ca2þ regulates S1P-stimulated PLD activ-
ity were then investigated. As illustrated in Fig. 3, calmodulin
(CaM) inhibitors W-7 and CGS9343B both reduced at a
signi¢cant extent activation of PLD by S1P, clearly demon-
strating that Ca2þ^CaM complex was implicated in the S1P-
evoked Ca2þ signaling leading to PLD activation; the insen-
sitivity to the speci¢c inhibitor KN-62 [19] suggested however
that CaM-dependent protein kinase II was not involved in the
process.
Fig. 1. E¡ect of Ca2þ on PLD activity in C2C12 cells. Serum-
starved myoblasts were labeled with [3H]glycerol and incubated
without (3) or with (+) Go«6976 (1 WM) 30 min prior to the addi-
tion of A23187 (3 WM) (¢lled bar) for 10 min in the presence of 2%
ethanol. Lipid extraction and [3H]PtdEtOH measurement were per-
formed as described in Section 2. Data are meansVS.E.M. of four
independent experiments performed in duplicate. The e¡ect of inhi-
bition was statistically signi¢cant (Student’s t-test, *P6 0.05).
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Given that the monomeric GTP-binding protein Ral partic-
ipates in some instances to PLD regulation [20,21] and is
stimulated in vitro by Ca2þ^CaM [22] and in vivo by Ca2þ
[23], next we examined whether Ral was activated by S1P.
Indeed, 30 s incubation in the presence of the bioactive lipid
provoked a speci¢c translocation of Ral to membranes, which
was similar to that induced by the rise of intracellular Ca2þ
elicited by A23187 (Fig. 4A). However, the mechanism by
which S1P activated Ral did not require Ca2þ, since the asso-
ciation of the GTPase to membranes was not signi¢cantly
diminished in Ca2þ-depleted cells (Fig. 4B). In the same ¢gure
the e¡ect of Ca2þ depletion on S1P-induced PKCK transloca-
tion is presented. Notably, in this experimental condition the
agonist-dependent association of PKCK to membranes was
impaired, implicating a Ca2þ-dependent event in S1P-induced
PKCK activation.
Finally, the potential involvement of calcineurin on S1P-
induced PLD activity was examined. As illustrated in Fig. 5,
cell treatment with 1 WM cyclosporin A, inhibitor of the CaM-
dependent protein phosphatase [24], signi¢cantly reduced the
extent of PLD activation by S1P, suggesting a role for calci-
neurin in PLD regulation.
Fig. 2. E¡ect of BAPTA/AM on Ca2þ increase and S1P-induced
PLD activation in C2C12 cells. A: Images represent the £uorescence
emission of Fluo-3 related to the Ca2þ level changes in cells treated
without or with 1 WM S1P for 40 s (T40). For the experiments myo-
blasts were plated on the coverslip, starved in serum-free medium
and incubated with or without BAPTA/AM (15 WM) for 1 h. Suc-
cessively, the cells were loaded with Fluo-3/AM (10 WM) for 10 min,
mounted on the stage of the confocal laser scanning microscope
and treated or not with the agonist. B: Serum-starved myoblasts la-
beled with [3H]glycerol were incubated with (+) or without (3)
BAPTA/AM (15 WM) 1 h prior to the stimulation with S1P (1 WM)
(¢lled bar) or BK (1 WM) (hatched bar) for 10 min in the presence
of 2% ethanol. Lipid extraction and [3H]PtdEtOH measurement
were performed as described in Section 2. Data are meansVS.E.M.
of at least three independent experiments performed in duplicate.
The e¡ect of inhibition was statistically signi¢cant (Student’s t-test,
*P6 0.05).
Fig. 3. E¡ect of W-7, CGS9343B and KN-62 on S1P-induced PLD
activation in C2C12 cells. Serum-starved myoblasts were labeled
with [3H]glycerol and incubated with vehicle (DMSO, 0.1%), W-7
(1 WM), CGS9343B (40 WM) or KN-62 (1 WM) 30 min prior to the
addition of S1P (1 WM) (hatched bar) for 10 min in the presence of
2% ethanol. Lipid extraction and [3H]PtdEtOH measurement were
performed as described in Section 2. Data are meansVS.E.M. of
four independent experiments performed in duplicate. The addition
of 0.1% DMSO (vehicle) did not change signi¢cantly basal PLD ac-
tivity. The e¡ect of the inhibition was statistically signi¢cant (Stu-
dent’s t-test, *P6 0.05).
Fig. 4. E¡ect of S1P and Ca2þ on membrane translocation of Ral
or PKCK in C2C12 cells. A: Serum-starved myoblasts were treated
with S1P (1 WM) or A23187 (3 WM) for 30 s. Protein aliquots
(15 Wg) of cytosolic (cyt) and particulate fractions (membr) were
separated by SDS^PAGE and transferred to nitrocellulose and im-
munodetected as described in Section 2. Experiment shown is repre-
sentative of at least three. Band intensity is reported as percentage
relative to control (no addition, 100%; meanVS.E.M. was less than
15%). B: Serum-starved myoblasts were incubated with or without
BAPTA/AM (15 WM) 1 h prior to the stimulation with S1P (1 WM).
Cells were collected and samples (25 Wg) of particulate fraction were
subjected to Western analysis using monoclonal anti-Ral or poly-
clonal anti-PKCK antibodies. Experiment shown is representative of
at least three. Band intensity is reported for each detected protein
as percentage (meanVS.E.M., n=4) relative to each control set as
100%.
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4. Discussion
A multitude of di¡erent studies have presented evidence for
a highly complex regulation of PLD by extracellular ligands.
In the present report it is clearly shown that stimulation of
PLD activity by S1P through speci¢c G-protein-coupled re-
ceptors, besides PKC and Rho proteins activation [6,10], also
requires Ca2þ increase. The here reported results con¢rm pre-
vious studies in which a role for Ca2þ in agonist-regulated
PLD was proposed, on the basis of the stimulatory e¡ect of
the enzymatic activity exerted by Ca2þ ionophores [25] and
the notion that both PLD isoforms, PLD1 and PLD2, are
sensitive to Ca2þ ions when overexpressed in insect Sf9 cells
[14]. Ca2þ increase evoked by S1P in mouse myoblasts was
here found to be required for PLD activation, although it was
not a prerequisite for agonist-dependent stimulation of PLD.
This latter ¢nding is consistent with the previously observed
role of PKCN in PLD regulation by S1P [6] and the dispens-
able role of Ca2þ in this signaling pathway. Notably, PLD
activity in S1P-stimulated myoblasts resulted to be in£uenced
by Ca2þ through di¡erent molecular mechanisms. First of all,
Ca2þ could activate PLD via PKCK regulation, as suggested
by two lines of evidence: the reduction of the e¡ect of the
Ca2þ ionophore A23187 on PLD activity by the conventional
PKC inhibitor Go«6976 and the inhibition of PKCK translo-
cation to membranes induced by S1P in Ca2þ-depleted cells.
Secondly, the stimulatory e¡ect of Ca2þ on PLD activity in-
duced by S1P was found to be dependent on Ca2þ^CaM
complex, as indicated by the sensitivity of the event to two
structurally di¡erent inhibitors, W-7 and CGS9343B. In
agreement with previous studies [26^28] Ca2þ^CaM was
found implicated in agonist-regulated PLD in C2C12 myo-
blasts. However, Ca2þ^CaM-dependent protein kinase II
was not apparently involved in PLD regulation, di¡erently
from what was observed in smooth muscle cells [28]. In search
for a possible e¡ector of CaM able to mediate Ca2þ-depen-
dent signaling of S1P to PLD, regulation of Ral by the bio-
active lipid was here investigated. Remarkably, the mono-
meric GTPase, known to participate to agonist-dependent
PLD regulation [20,21], was relocalized to membranes by
S1P, indicating that it may play a role in S1P signaling. How-
ever, despite translocation of Ral to membranes resulted to be
promoted by Ca2þ rise, the S1P e¡ect on Ral was una¡ected
by cytosolic Ca2þ depletion. This ¢nding rules out that Ral
could act as e¡ector of Ca2þ in the signaling of S1P to PLD in
myoblasts, although it does not exclude the involvement of
Ral in PLD regulation through a Ca2þ-independent signaling
cascade.
Another major ¢nding of this study is that calcineurin very
likely acts as e¡ector of Ca2þ^CaM in the S1P-mediated PLD
activation, as inferred by the signi¢cant reduction of S1P ef-
fect by cyclosporin A. However, the molecular mechanism by
which the serine/threonine protein phosphatase exerts a pos-
itive e¡ect on PLD activity is at present unknown. It can be
speculated that PLD acts as substrate of calcineurin and is
more active in the dephosphorylated form. This hypothesis is
in keeping with the ¢nding that PLD2 is inhibited by serine/
threonine phosphorylation [29]. Alternatively, calcineurin
could indirectly in£uence PLD activity by acting on one or
more of its numerous regulators.
From this study it emerges that Ca2þ response evoked by
S1P plays a role in the control of PLD and that CaM and
calcineurin are implicated in this molecular event. In view of
the key role exerted by these proteins in muscle cell biology
[30], it will be of interest to examine whether calcineurin is
critical for biological action of S1P in skeletal muscle and
PLD activation represents a key element in its signaling ma-
chinery.
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